Hepatitis A, B, and C Prevention Programs
Information and Programs for Adults and Adolescents at Risk
 
  Home
  Hep Express archives
    Search
 

Prevention Programs

  APIA programs
  Corrections, adult
  Corrections, juvenile
  Family planning
  Harm reduction
  Homeless programs
  MSM
  Perinatal related
  School programs
  STD/HIV
  Other programs
  Index of programs
    Support Group Info
  Hepatitis B
  Hepatitis C
  Listed by state
    Hepatitis B Info
  FAQ about hep B
  VISs
  Laws and mandates
  Case histories
  Photos
  Videos
    Hepatitis A Info
  FAQ about hep A
  VISs
  Laws and mandates
  Case histories
  Photos
    Hep-related Topics
  International adoption
  Tattooing and piercing
  Travel vaccination
  Healthcare workers
  Needle safety
  Dialysis
    Other Information
  CDC website
  Hep organizations
  NASTAD website
  Contact NASTAD
  About NASTAD
  Privacy policy
 

(click on the image)




STD/HIV clinics
Harm reduction

 
Injection Drug User (IDU) HIV Counseling and Testing Utilizing HCV Screening High-Risk Initiative
Program name: Injection Drug User (IDU) HIV Counseling and Testing Utilizing HCV Screening High-Risk Initiative
Population served: IDUs in 24 local health jurisdictions in California
Eligibility: Clients at risk of hepatitis C virus (HCV) infection who are IDUs
Region served: 24 local health jurisdictions in California
Funding: California Department of Health Services, Office of AIDS
Program started: 2004
Number of clients:  
Contact: Alessandra Ross
Injection Drug Use Policy and Program Coordinator
California Department of Public Health, Office of AIDS
MS 7700, P.O. Box 997426
Sacramento, CA 95814
Phone: (916) 449-5796
Fax: (916) 449-5800
Email: alessandra.ross@cdph.ca.gov
Website: www.dhs.ca.gov/AIDS
IAC is not responsible for content found on other websites.
Description:
In 2003, California Department of Health Services, Office of AIDS (CDHS/OA) conducted a demonstration project to evaluate the use of HCV counseling and testing (C&T) as an incentive to attract larger numbers of IDUs into HIV C&T. Among the results:
  • HIV testing rates among IDUs nearly doubled when HIV C&T was offered in conjunction with HCV C&T;
  • HIV test disclosure return rates increased by 21 percent among IDUs when individuals were able to receive both their HCV and HIV test results; and
  • IDUs were more interested in their HCV status than their HIV status.

In 2004, as a result of the demonstration project, the California Department of Health Services, Office of AIDS implemented the Injection Drug User HIV Counseling and Testing Utilizing HCV Screening High-Risk Initiative in 24 local health jurisdictions. The intent of the Initiative is to better understand how alternative approaches, including incentives, influence the number of IDUs who enter into HIV C&T programs in California. The Initiative’s objective is to increase the number of IDUs who receive HIV C&T. The goals are:

  • Primary goal – offering HCV screening in coordination with HIV C&T.
  • Secondary goal - integrating HCV testing into HIV C&T to increase the number of IDUs who know their HCV status, and receive appropriate HCV prevention; and to link infected persons to HCV care services.

Data collected from the Initiative will help local health jurisdictions to better understand HCV infection rates and related risk behaviors in their respective jurisdictions. Such knowledge can also assist county and state health officials to better address the prevention, treatment, and funding needs among IDUs related to HCV and HIV infection.

Helpful resources:


Nastad
www.nastad.org
nastad@nastad.org
          Hepatitis Prevention Programs
www.hepprograms.org
nastad@nastad.org

444 North Capitol Street, NW • Suite 339 • Washington D.C. 20001 • (202) 434-8090